A Human-Pathogen SEIR-P Model for COVID-19 Outbreak under different Intervention scenarios in Kenya =================================================================================================== * Viona Ojiambo * Mark Kimathi * Samuel Mwalili * Duncan Gathungu * Rachel W. Mbogo ## Abstract This work describes the mathematical modelling and dynamics of a novel Coronavirus disease 2019 (COVID-19) in Kenya. The mathematical model assumes Human-Human infection as well as Human-Pathogen interaction. Using the SEIR (Susceptible-Exposed-Infected-Recovered) compartmental model with additional component of the pathogen,we simulated the dynamics of COVID-19 outbreak and impact of different control measures. The resulting system of ordinary differential equations (ODEs) are directly solved using a combination of fourth and fifth-order Runge-Kutta methods. Simulation results indicate that non-pharmaceutical measures such as school closure, social distancing and movement restriction emphatically flatten the epidemic peak curve hence leading to a smaller number of overall disease cases. Keywords * SEIR-P * basic reproductive number * COVID-19 * simulation * intervention * SARS-CoV-2 ## Introduction COVID-19 is an infectious disease that is caused by SARS-CoV-2 which is a newly 2 emergent virus that has attracted alot of scientific research. The first reported case 3 began in mainland China, City of Wuhan, Hubei on 29th December 2019. [1]. Later on, 4 the novel disease began to spread to countries in contact with China resulting to WHO 5 declaring it as a Public Health Emergency of International Concern (PHEIC) on 30 6 January 2020 [2]. As of 17th April 2020 the number of reported confirmed cases had 7 exceeded two million [3]. The United States of America (USA) was on the lead with 8 infections while Italy followed put. Africa was also affected by imported cases that 9 resulted to the first Kenyan case being reported on the 13th of March 2020 [4]. 10 The three main types of infections of COVID-19 are asymptomatic, pre-asymptomatic 11 and symptomatic. The incubation period for COVID-19 in the pre-assymptomatic 12 infectious group, which is the time between exposure to the virus (becoming infected) 13 and symptom onset, is on average 5–6 days, however it can be up to 14 days. During 14 this period some infected persons can be contagious. In a symptomatic COVID-19 case, 15 the disease manifests itself with signs and symptoms. Asymptomatic transmission refers 16 to transmission of the virus from a person, who does not develop symptoms [5]. The basic reproductive number, defined as the average number of secondary infections 18 produced by a typical case of an infection in a population where everyone is susceptible [6], is affected by the rate of contacts in the host population, the probability 20 of infection being transmitted during contact and the duration of infectiousness. The 21 basic reproductive number for COVID-19 in Kenya ranges from 1.78(95%CI 1.44–2.14) 22 to 3.46 (95%CI 2.81–4.17) [7]. The outbreak is thought to spread through a population via direct contact with 24 infectious individuals [8] or cross transmission through pathogen contamination in the 25 environment. Specifically, the virus is primarily spread between people during close 26 contact,often via small droplets produced by coughing,sneezing, or talking [9] [10] [5] [6] [13]. After breathing out produces these droplets, they usually fall 28 to the ground or on to surfaces rather than remain in the air over long distances [9] [6] [7]. People may also become infected by touching a contaminated 30 surface and then touching their eyes, nose, or mouth. [9] [10]. The virus can survive on 31 surfaces for up to 72 hours [13]. This kind of transmission has had adverse social and economic impact because all 33 segments of the population are significantly affected. The disease is particularly 34 detrimental to vulnerable social groups such as older age-groups, persons with 35 disabilities and people with other underlying diseases. If the pandemic is not properly 36 addressed through policy, the social crisis generated from COVID-19 could also increase 37 inequality, exclusion, discrimination and global unemployment in the medium and long 38 term [11]. Inorder to achieve suitable control measures of COVID-19, an accurate SEIR 39 mathematical prediction model is required. Regrettably, this can only be obtained after 40 the outbreak ends since the prediction trends are largely influenced by each country’s 41 policy and social responsibility [12]. Mathematical models can help us to understand how SARS-CoV-2 could spread across 43 the population and inform control measures that might mitigate future transmission [13]. Non-pharmaceutical interventions based on sustained physical 45 distancing have a strong potential to reduce the magnitude of the epidemic peak of 46 COVID-19 and lead to a smaller number of overall cases. In the absence of a vaccine 47 social distancing has become the most appropriate Non Pharmaceutical Intervention 48 (NPIs) [14]. Lowering and flattening of the epidemic peak is paramount, as this reduces 49 the acute pressure on the health-care system. Premature and sudden lifting of 50 interventions could lead to an earlier secondary peak, which could be flattened by 51 relaxing the interventions gradually [15]. According to the WHO/China Joint Mission Report, 80% of laboratory-confirmed cases 53 in China up to 20 February 2020 have had mild-to moderate disease – including both 54 non-pneumonia and pneumonia cases; whilst 13.8% developed severe disease and 6.1% 55 developed to a critical stage requiring intensive care [16]. It is therefore paramount to 56 come up with an epidemiological model that factors in hospitalization of the mild to 57 moderate cases and severity of the disease. In a recent study we explored an SEIR-P model that incorporates human behavior 59 during the disease outbreak, such as ignorance of social distancing so as to advise health 60 experts was developed. The model also accounted for individuals with robust 61 immune [17]. The model in this study is different because (i) It does not include 62 individuals with robust immunities because this research has not been fully concluded. (ii) Compartments of hospitalized population *H*(*t*), human population in Intensive Care Unit *U*(*t*) and the fatalities *D*(*t*) have been added to the SEIR-P model so as to 65 account for the aforementioned dynamics [16]. (iii)It investigates the effects of lifting 66 non-Pharmaceutical interventions such as school closure, physical distancing and 67 lockdown on the model. It is envisaged that the dynamics of the results shall inform 68 health experts in their research of efficient and effective ways of flattening the curve. ## Materials and methods ### Model formulation In this study a human-Pathogen SEIR-P model for COVID-19 outbreak is formulated. 72 The model considers a short-time period thereby ignoring the demographics of births 73 and natural death. The total human population is subdivided into the susceptible 74 human beings *S*(*t*), the exposed human beings *E*(*t*), the asymptomatic infectious 75 population *IA*(*t*), the symptomatic infectious population *IM*(*t*), the critical infectious 76 population *IC*(*t*), the hospitalized population *H*(*t*) in ordinary wards and *U*(*t*) in 77 Intensive Care Unit, the fatalities *D*(*t*) and the recovered population *R*(*t*). The 78 Pathogen vector in the environment is denoted by *P*(*t*). The model in Figure 1 culminates to a ten dimensional system of ordinary differential 80 equations as follows; ![Formula][1] with the initial conditions: ![Formula][2] Fig 1. Compartmental model of the SEIR model of transmission of COVID-19 The terms ![Graphic][3] and ![Graphic][4] denote the rate at which the susceptible 83 individuals *S*(*t*) gets infected by the pathogens from environment *P* (*t*), infectious 84 humans *IA*(*t*), *IM*(*t*) and *IC*(*t*), and hospitalized humans *U*(*t*) and *H*(*t*) respectively. A 85 quarter of reported cases of COVID-19 are mainly asymptomatic infectious, *IA*(*t*) while 86 the larger group is mild infectious, *IM*(*t*) with a smaller proportion being critical 87 infectious, *IC*(*t*). *IA*(*t*) may join the recovery group *R*(*t*) or seek medical intervention 88 from *H*(*t*). *IM*(*t*) and *IC*(*t*) may go to hospital *H*(*t*), but upon critical diagnosis be 89 referred to the ICU *U*(*t*) which may result to fatalities *D*(*t*) or recovery *R*(*t*). The table 90 of parameters is as shown below. The parameters used in the COVID-19 transmission 91 model are given in the table 1 below. ### Disease Free Equilibrium (DFE) and Basic Reproduction Number In the DFE there are no infections from the humans nor the pathogens such that 95 *S* = *N*. This implies that *P* = *IA* = *IM* = *IC* = *U* = *H* = 0 which further implies that *E* = *D* = *R* = 0. The Basic Reproduction Number *R*, is defined as the average number of secondary 98 infections produced by a typical case of an infection in a population where everyone is 99 susceptible [6]. This number is affected by the rate of contacts in the host population, 100 the probability of infection being transmitted during contact and the duration of 101 infectiousness. The next generation matrix method is used to obtain the *R*. Let *x* = (*E, IA, IM, IC, H, U, P*)*T* then the model can be written as ![Graphic][5] ![Formula][6] ![Formula][7] Evaluating the derivatives of F and V at the Disease Free Equilibrium yields matrix **F** and **V** as follows; ![Formula][8] ![Formula][9] Substituting, (*ξ* + *λH* + *γH*) (*φ* + *λU*) = *C*5*C*6 *− ξφ* = *C*1, *λC* + *τC* = *C*2,*τA* + *γA* = *C*3, (*φ* + *λU*) *− ξφ* = *C*6 *− ξφ* = *C*4, *ξ* + *λH* + *γH* = *C*5 and *φ* + *λU* = *C*6 in matrix V yields ![Formula][10] The inverse of matrix **V** is determined as ![Formula][11] The product **FV−1** results to; ![Formula][12] where ![Formula][13] *R* is the spectral radius of the product **FV−1** that results to; ![Formula][14] Here *R* is the sum of three terms representing the average new infections contributed by 115 each of the three infectious classes; pathogens, infectious groups (mild, assymptomatic 116 and critical) and hospitalized groups denoted by *β*1,*β*2, and *β*3 respectively. ## Results and Discussion A cure or vaccine for COVID-19 is yet to be discovered. Therefore, the interventions 119 being carried out are non-pharmaceutical and include measures such as contact tracing, 120 quarantine, social distancing, wearing of face masks, and hand washing. Mass testing 121 and effective contact tracing has been a great challenge in low-income countries. Therefore, these countries have adopted social distancing measures such as closure of 123 schools, reducing sizes of gatherings, minimizing contact in workplaces, and imposing 124 curfews. The main aim of such interventions is to flatten the curve i.e. prevent infection 125 from spreading fast and bring down the number of infected cases. Curve flattening is 126 necessary because it avoids overwhelming the health systems and gives them time to 127 develop treatment mechanisms. A key factor in slowing infection spread is reduction of the basic reproduction number *R*, which is expressed in terms of the rates of new infections *β*1,*β*2, and *β*3. Thus, we 130 implement the non-pharmaceutical interventions (NPIs) by multiplying the rates of 131 infections by a 20% and 30% factor. The interpretation is that the NPIs yield an overall 132 mitigation of the epidemic spread by 20% and 30% respectively. An attack rate of 67% 133 was assumed. This led to considering total population *N* as the product of attack rate 134 and the total population of Kenya, which is approximately 5.02 *×* 107. An identification 135 rate *p* of the new infectious cases was determined as the ratio of confirmed cases over 136 the total number of tested individuals. At the time of this study *p* was 0.02, while the 137 parameter values were taken as shown in Table 1 above. The simulation was initialized 138 at date 13–3–2020 and run for 365 days with the initial values *IA*(0) = 2, *IM*(0) = 2, *IC* (0) = 2, and *P* (0) = 5, 000, while the other variables (except *S*(0)) were initially set 140 to 0. View this table: [Table 1.](http://medrxiv.org/content/early/2020/05/20/2020.05.15.20102954/T1) Table 1. Description of model parameters. The results of the infectious (*IA* + *IM* + *IC*) and hospitalized (*H* + *U*) cases in Kenya are shown in Figure 2, and epidemic peak values and dates are depicted in Table 2. In unmitigated situation, the peak arrives rather quickly, in about 4 months probably 144 due to the asymptomatics significantly contributing to the epidemic spread. We note 145 that the Kenyan population is largely comprised of youth, who are majorly presumed to 146 be an asymptomatic population. Our model predicts that if the overall control measures 147 achieves 20% effectiveness in slowing the spread of COVID-19, then a delay of slightly 2 148 months is realized, which allows the health care systems time of gathering resources to 149 manage the epidemic. Consequently, the reported infectious and hospitalized cases are 150 reduced by more than 50%. However, there is a likelihood of exceeding the health 151 capacities. A 30% effectiveness of the applied NPIs substantially bring the epidemic 152 further down, and as noted in Figure 3 the simulated cumulative infectious cases 153 largely coincides with the data of COVID-19 epidemic in Kenya. Moreover, this 154 particular mitigation effort reduce the cumulative infectious cases from just under 700,000 down to around 450,000 cases by date 13-Mar-2021. A similar reduction is also 156 seen in the cumulative number of hospitalized cases. Moreover, the cumulative deaths 157 attains a more than 50% reduction, from about 6,000 cases in unmitigated situation to 158 around 3,500 cases in the 30% mitigation scenario. Majority of deaths emanate from 159 those already in intensive care unit (ICU) *U*, which is presumably overwhelmed by the 160 many critically ill patients arising from *H* and *IC* populations. The inability to access 161 the limited ICU resources results to additional deaths from *H* and *IC* populations. The control measures were put in place for the entire simulation time, so there was 163 no rebound of the infections. A strong one-time social distancing measure would not 164 sufficiently prevent overwhelming of the health care capacities, since it keeps a 165 significant number of the population in susceptible compartment such that a rebound in 166 infections, after the measure has been lifted, will lead to an epidemic wave that 167 surpasses the capacity. Moreover, previous studies have shown that intermittent 168 application of the NPIs maintains the infections within the health care capacities, but 169 prolongs the total duration of the epidemic. ![Fig 2.](http://medrxiv.org/https://www.medrxiv.org/content/medrxiv/early/2020/05/20/2020.05.15.20102954/F2.medium.gif) [Fig 2.](http://medrxiv.org/content/early/2020/05/20/2020.05.15.20102954/F2) Fig 2. Left panels depicts simulation of infectious and hospitalized cases, in unmitigated and mitigated situations. The implementation of NPIs results to a delay and significant reduction in the cases, as shown by the varying peaks. Right panels show the simulated cumulative cases for both infectious and hospitalized individuals. The infectious cases comprise of individuals in compartments *IA, IM*, and *IC* cases.The hospitalized cases comprise of individuals in compartments *H* and *U*. View this table: [Table 2.](http://medrxiv.org/content/early/2020/05/20/2020.05.15.20102954/T2) Table 2. Simulated peaks of infectious and hospitalized cases, with the associated peak dates. ![Figure 3.](http://medrxiv.org/https://www.medrxiv.org/content/medrxiv/early/2020/05/20/2020.05.15.20102954/F3.medium.gif) [Figure 3.](http://medrxiv.org/content/early/2020/05/20/2020.05.15.20102954/F3) Figure 3. Left panel depicts the data of the confirmed cases in Kenya against the simulated infectious cases for the first 60 days, in unmitigated and mitigated situations. The simulated results of a 30% NPIs effectiveness coincides with the data. Right panel show the cumulative deaths, which decline significantly as the NPIs take effect. ## Conclusion An SEIR-P compartmental model has been used to study the spread of COVID-19. The 172 model accounts for both human to human and human-environment interactions. The 173 model simulations underscores the fact that NPIs such as school closure, social 174 distancing and movement restriction emphatically delay or flatten the epidemic peak. ## Data Availability The data used to support findings of this study is available from the corresponding author upon request. ## Acknowledgements The authors appreciate ample time given by their respective universities towards this 177 manuscript. * Received May 15, 2020. * Revision received May 15, 2020. * Accepted May 20, 2020. * © 2020, Posted by Cold Spring Harbor Laboratory The copyright holder for this pre-print is the author. All rights reserved. The material may not be redistributed, re-used or adapted without the author's permission. ## REFERENCES 1. 1.Liu T, Hu J, Kang M, Lin L, Zhong H, Xiao J, et al. Transmission dynamics of 2019 novel coronavirus (2019-nCoV). Available: [https://www.biorxiv.org/content/10.1101/2020.01.25.919787v1.full.pdf](https://www.biorxiv.org/content/10.1101/2020.01.25.919787v1.full.pdf) 2. 2.World Health Organization (WHO) Statement on the second meeting of the International Health Regulations. Emergency Committee regarding the outbreak of novel coronavirus (2019-nCov). 2020 3. 3.World Health Organization (WHO) Situation report 88. Available: [https://www.who.int/docs/default-source/coronaviruse/situation-reports/20200417-sitrep-88-covid-19](https://www.who.int/docs/default-source/coronaviruse/situation-reports/20200417-sitrep-88-covid-19). 4. 4.Ministry of Health COVID-19 news update. 2020. Available: [http://www.health.go.ke/](http://www.health.go.ke/) 5. 5.World Health Organization (WHO) Situation report 73. Available: [https://www.who.int/docs/default-source/coronaviruse/situation-reports](https://www.who.int/docs/default-source/coronaviruse/situation-reports) 6. 6.Qun L., Xuhua G., Peng W., Xiaoye W., Lei Z. et al. Early transmission dynamics in Wuhan, China, of novel coronavirus-infected pneumonia. The New England Journal of Medicine. 2020;382: 1199–1207 7. 7.Brand S., Aziza R., Kombe I., Agoti C., Hilton J., et al. Forecasting the Scale of the COVID-19 Epidemic in Kenya. BMJ. MedRXiv.2020. Available: [https://doi.org/10.1101/2020.04.09.20059865](https://doi.org/10.1101/2020.04.09.20059865) 8. 8.Huang CL, Wang YM, Li XS, Ren LL, Zhao JP, Hu Y, et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. The Lancet. 2020 Feb;395 (10223): 497–506 [PubMed](http://medrxiv.org/lookup/external-ref?access_num=http://www.n&link_type=MED&atom=%2Fmedrxiv%2Fearly%2F2020%2F05%2F20%2F2020.05.15.20102954.atom) 9. 9.World Health Organization (WHO) Report of the WHO-China Joint Mission on Coronavirus Disease 2019 (COVID-19). Available:[https://www.who.int/docs/default-source/coronaviruse/who-china-joint-mission-on-covid-19-final-report.pdf](https://www.who.int/docs/default-source/coronaviruse/who-china-joint-mission-on-covid-19-final-report.pdf) 10. 10.Ong SW, Tan YK, Chia PY, Lee TH, Ng OT, Wong MS, et al. Air, surface environmental, and personal protective equipment contamination by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) from a symptomatic patient. JAMA. 2020. Epub ahead of print 11. 11.United Nations: Department of Economic and Social Affairs Inclusion Everyone Included Social Impact of COVID-19. Available: [https://www.un.org/development/desa/dspd/everyone-included-covid-19.html](https://www.un.org/development/desa/dspd/everyone-included-covid-19.html). 12. 12.Riley S, Fraser C, Donnelly CA, et al. Transmission dynamics of the etiological agent of SARS in Hong Kong: impact of public health interventions. Science. 2003 300:1961–66. [Abstract/FREE Full Text](http://medrxiv.org/lookup/ijlink/YTozOntzOjQ6InBhdGgiO3M6MTQ6Ii9sb29rdXAvaWpsaW5rIjtzOjU6InF1ZXJ5IjthOjQ6e3M6ODoibGlua1R5cGUiO3M6NDoiQUJTVCI7czoxMToiam91cm5hbENvZGUiO3M6Mzoic2NpIjtzOjU6InJlc2lkIjtzOjEzOiIzMDAvNTYyNy8xOTYxIjtzOjQ6ImF0b20iO3M6NTA6Ii9tZWRyeGl2L2Vhcmx5LzIwMjAvMDUvMjAvMjAyMC4wNS4xNS4yMDEwMjk1NC5hdG9tIjt9czo4OiJmcmFnbWVudCI7czowOiIiO30=) 13. 13.Binti Hamzah FA, Lau C, Nazri H, Ligot DV, Lee G, Tan CL, et al. CoronaTracker: Worldwide COVID-19 Outbreak Data Analysis and Prediction. Bull World Health Organ. 2020. Available: [http://dx.doi.org/10.2471/BLT.20.255695](http://dx.doi.org/10.2471/BLT.20.255695). 14. 14.Ferguson N, Laydon D, Nedjati G. Impact of non-pharmaceutical interventions (NPIs) to reduce COVID-19 mortality and healthcare demand. Available: [https://doi.org/10.25561/77482](https://doi.org/10.25561/77482). 15. 15.Kiesha P, Yang L, Timothy W, Adam J, Rosalind ME, Nicholas D, et al. The effect of control strategies to reduce social mixing on outcomes of the COVID-19 epidemic in Wuhan, China: a modelling study. Available: [https://doi.org/10.1016/S246802667(20)30073-6](https://doi.org/10.1016/S246802667(20)30073-6) 16. 16.World Health Organization (WHO) Report of the WHO-China Joint Mission on Coronavirus Disease 2019 (COVID-19). 2020. 17. 17.Mwalili S., Kimathi M., Ojiambo V., Gathungu D., Mbogo R. SEIR Model for COVID-19 Dynamics Incorporating the Environment and Social Distancing. Available: doi:10.21203/rs.3.rs-19249/v1. [CrossRef](http://medrxiv.org/lookup/external-ref?access_num=10.21203/rs.3.rs-19249/v1&link_type=DOI) [1]: /embed/graphic-1.gif [2]: /embed/graphic-2.gif [3]: /embed/inline-graphic-1.gif [4]: /embed/inline-graphic-2.gif [5]: /embed/inline-graphic-3.gif [6]: /embed/graphic-3.gif [7]: /embed/graphic-4.gif [8]: /embed/graphic-5.gif [9]: /embed/graphic-6.gif [10]: /embed/graphic-7.gif [11]: /embed/graphic-8.gif [12]: /embed/graphic-9.gif [13]: /embed/graphic-10.gif [14]: /embed/graphic-11.gif